{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":3,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":3,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12","author_layer_release":"2026-06-26"},"query_hash":"8a888064ae0e","filters":{"venue":"Hematologic malignancies"}},"results":[{"id":"W2127646700","doi":"10.1007/978-3-319-12505-3_24","title":"Second Malignancy Risk After Treatment of Hodgkin Lymphoma","year":2014,"lang":"en","type":"book-chapter","venue":"Hematologic malignancies","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Breast cancer; Cancer; Internal medicine; Malignancy; Lung cancer; Oncology; Relative risk; Population; Absolute risk reduction; Radiation therapy","authors":[{"name":"David Hodgson","is_ca":true},{"name":"Flora E. van Leeuwen","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01940116088779189,"gpt":0.2364509846356947,"spread":0.2170498237479028,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001873285,0.0001992124,0.0002318583,0.0002764208,0.0002018529,0.0006193182,0.0002479902,0.0005230677,0.01579677],"category_scores_gemma":[0.0009367611,0.00008322798,0.0002493837,0.0002441113,0.0001268319,0.0004698083,0.0002931528,0.001061713,0.002005367],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000543884,"about_ca_system_score_gemma":0.0005662185,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001668035,"about_ca_topic_score_gemma":0.004856056,"domain_scores_codex":[0.9999093,0.0000221971,0.000004530194,0.00001107922,0.00004248803,0.00001047707],"domain_scores_gemma":[0.9998055,0.0001233627,0.00002075272,0.000006108398,0.00002240419,0.00002192581],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.00007293809,0.0001202222,0.007175947,0.0004861489,0.00004369127,0.001827483,0.000446489,0.0008865676,0.0005550544,0.03178325,0.337928,0.6186742],"study_design_scores_gemma":[0.00001349042,0.0001650621,0.02147496,0.001587435,0.00004860534,0.01824259,0.0003891382,0.0005435268,0.0005082764,0.03080116,0.926201,0.00002471635],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"other","genre_gemma":"empirical","genre_scores_codex":[0.0213796,0.3354782,0.005308187,0.02808308,0.006698878,0.00004236186,0.0008600903,0.0002021613,0.6019475],"genre_scores_gemma":[0.1499719,0.2828668,0.004725062,0.01309462,0.009423391,0.00007974391,0.001140264,0.000149972,0.5385482],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.01579677,"threshold_uncertainty_score":0.05284542,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4233452951","doi":"10.1007/978-3-030-32482-7_26","title":"Second Malignancy Risk After Treatment of Hodgkin Lymphoma","year":2020,"lang":"en","type":"book-chapter","venue":"Hematologic malignancies","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Hodgkin lymphoma; Medicine; Malignancy; Lymphoma; Oncology; Internal medicine","authors":[{"name":"Michael Schaapveld","is_ca":false},{"name":"David Hodgson","is_ca":true},{"name":"Flora E. van Leeuwen","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02560708882478763,"gpt":0.2387081235047815,"spread":0.2131010346799938,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001617661,0.0001859541,0.0002164863,0.0002510936,0.0002086693,0.0006176323,0.000235746,0.0004757126,0.02180943],"category_scores_gemma":[0.0008470317,0.00007758196,0.0002531626,0.00027604,0.00009426519,0.0003720853,0.0002673405,0.0008238103,0.002177478],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004717478,"about_ca_system_score_gemma":0.0004503538,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001583778,"about_ca_topic_score_gemma":0.005486004,"domain_scores_codex":[0.999918,0.00002091708,0.000003332589,0.000008284325,0.00003886407,0.00001062563],"domain_scores_gemma":[0.9997484,0.0001629992,0.00003024086,0.000007715865,0.00002206888,0.00002851375],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.0001524263,0.0002164187,0.01801936,0.0005846052,0.00005967427,0.003022188,0.0005280219,0.001272702,0.0008244794,0.02494481,0.3248343,0.625541],"study_design_scores_gemma":[0.00001904549,0.0004085753,0.06064971,0.001457673,0.00007627355,0.02883445,0.0005309413,0.0008714481,0.000663198,0.02077347,0.8856888,0.00002638134],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"other","genre_gemma":"empirical","genre_scores_codex":[0.03158222,0.212961,0.002988244,0.01596854,0.004029529,0.00003876779,0.0008929562,0.0001644284,0.7313744],"genre_scores_gemma":[0.1774066,0.1627876,0.002429401,0.006931304,0.006317416,0.00006113877,0.001011213,0.0001093921,0.6429459],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.02180943,"threshold_uncertainty_score":0.07295978,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3094050214","doi":"10.1007/978-3-030-57317-1_2","title":"Antibacterial and Antiparasitic Prophylaxis","year":2020,"lang":"en","type":"book-chapter","venue":"Hematologic malignancies","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Medicine; Hematological malignancy; Intensive care medicine; Antimicrobial; Immunosuppression; Mortality rate; Adverse effect; Internal medicine","authors":[{"name":"Mohammed Alsaeed","is_ca":false},{"name":"Shahid Husain","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02813957360811738,"gpt":0.253014325127207,"spread":0.2248747515190896,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002277691,0.0007080198,0.0004023026,0.001017508,0.00045476,0.001362027,0.0005421377,0.001006449,0.06153365],"category_scores_gemma":[0.0004471378,0.0001894923,0.0002669201,0.0007233673,0.0004216864,0.00111435,0.0007827068,0.00198332,0.0298184],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005468136,"about_ca_system_score_gemma":0.0006181246,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001054531,"about_ca_topic_score_gemma":0.004654224,"domain_scores_codex":[0.9998727,0.00002829769,0.00000568877,0.00001305567,0.00006723115,0.00001302315],"domain_scores_gemma":[0.9998831,0.00006208177,0.000008392764,0.000008327197,0.00002393475,0.00001417165],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0000261714,0.0001170887,0.00008679559,0.0004562982,0.000005263668,0.0002522526,0.0001619401,0.0003788329,0.001237129,0.04894371,0.5083736,0.4399609],"study_design_scores_gemma":[0.000001652731,0.0000109731,0.0000900178,0.0001377219,0.000001677191,0.0002991322,0.00001942849,0.00004698031,0.0001149211,0.004581509,0.9946937,0.000002287425],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"other","genre_gemma":"other","genre_scores_codex":[0.0005795498,0.09629,0.003391028,0.003217709,0.004484571,0.00004950196,0.0001772446,0.0001647116,0.8916458],"genre_scores_gemma":[0.002034933,0.03833217,0.002351838,0.002962062,0.001620968,0.00003990676,0.0001239867,0.00007057165,0.9524636],"genre_candidate":"other","genre_consensus":"other","teacher_disagreement_score":0.06153365,"threshold_uncertainty_score":0.2058506,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}